Increasing findings have shown that human SLFN5 functions in malignant tumors, such as melanoma, renal cell carcinoma, and glioblastoma, where it seems to play differential roles, either inhibitory or permissive. The gene discussed is SLFN5; the disease is hereditary clear cell renal cell carcinoma.